Masaru Sumi

Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial

PK Judge, Natalie Staplin, KJ Mayne et al. · The Lancet Diabetes & Endocrinology · 2023 · 108 citations · Full text

Medicine, Nephrology, Pharmacotherapy +11

Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the empa-kidney trial

Natalie Staplin, Richard Haynes, PK Judge et al. · The Lancet Diabetes & Endocrinology · 2023 · 90 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +14

New Synthetic Quinolone Antibacterial Agents and Serum Concentration of Theophylline

Yoshihito Niki, Rinzō Soejima, Hiroshi Kawane et al. · CHEST Journal · 1987 · 57 citations

Pharmacy, Medicinal Chemistry, Pharmacotherapy +12

Concentrations of superoxide dismutase and superoxide anion in blood of patients with respiratory infections and compromised immune systems.

Shigenobu Umeki, Masaru Sumi, Y Niki et al. · Clinical Chemistry · 1987 · 29 citations · Full text

Life Sciences, Immunology, Infectious Diseases +16